Literature DB >> 31809356

Management of Osteoporosis in Patients Living With HIV-A Systematic Review and Meta-analysis.

Jakob Starup-Linde1, Simone Bruhn Rosendahl1,2, Merete Storgaard2, Bente Langdahl1.   

Abstract

OBJECTIVE: Osteoporosis is reported as a common comorbidity in patients living with HIV (PLHIV). The aim of this systematic review and meta-analysis is to assess the evidence on fracture risk in PLHIV, bone mineral density (BMD) in PLHIV compared with controls, longitudinal changes in BMD in PLHIV, and effect of antiosteoporosis treatment in PLHIV.
METHODS: A systematic literature search was conducted using the databases Medline at PubMed and EMBASE using the search terms: "HIV" and "fracture" or "bone turnover," or "bone mineral density." Eligibility criteria followed the aim of the study and include randomized controlled trials and observational studies. Two reviewers extracted the data independently. Meta-analysis was performed using random-effects model assessing fracture risk, BMD compared with controls, and changes in BMD.
RESULTS: One hundred forty-two of 2397 papers identified were included in the systematic review, and subsequently, 84 were included in the meta-analysis. The risks of a fragility fracture [1.51, 95% confidence interval (CI): 1.41 to 1.63] and hip fracture (4.05, 95% CI: 2.99 to 5.49) were increased. PLHIV have lower BMD at the hip (z-score -0.31, 95% CI: -0.46 to -0.27) and lumbar spine (z-score -0.36, 95% CI: -0.39 to -0.15) compared with controls. The reduced BMD did not fully explain the increased fracture risk in PLHIV.
CONCLUSIONS: Current management of osteoporosis in PLHIV follows general osteoporosis guidelines; however, the increased fracture risk is not fully explained by lower BMD, and thus, antiosteoporosis intervention may be beneficial at a higher BMD in PLHIV.

Entities:  

Mesh:

Year:  2020        PMID: 31809356     DOI: 10.1097/QAI.0000000000002207

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  16 in total

1.  Risk Factors, Screening, Diagnosis, and Treatment of Osteoporosis in HIV-Infected Adults in an HIV Primary Care Clinic.

Authors:  Kevin Kwok; Caitlin Olatunbosun; Erin Ready; Osric Sin; Junine Toy; Alena Spears; Vickie Lau; Greg Bondy; Sarah Stone
Journal:  Can J Hosp Pharm       Date:  2022-07-04

Review 2.  Bone Quality in Relation to HIV and Antiretroviral Drugs.

Authors:  Arnold Z Olali; Kelsey A Carpenter; Maria Myers; Anjali Sharma; Michael T Yin; Lena Al-Harthi; Ryan D Ross
Journal:  Curr HIV/AIDS Rep       Date:  2022-06-20       Impact factor: 5.495

3.  Brief Report: Are Serious Falls Associated With Subsequent Fragility Fractures Among Veterans Living With HIV?

Authors:  Julie A Womack; Terrence E Murphy; Christine Ramsey; Harini Bathulapalli; Linda Leo-Summers; Alexandria C Smith; Jonathan Bates; Samah Jarad; Thomas M Gill; Evelyn Hsieh; Maria C Rodriguez-Barradas; Phyllis C Tien; Michael T Yin; Cynthia Brandt; Amy C Justice
Journal:  J Acquir Immune Defic Syndr       Date:  2021-10-01       Impact factor: 3.771

Review 4.  Dilemmas in the Management of Osteoporosis in Younger Adults.

Authors:  Madhuni Herath; Adi Cohen; Peter R Ebeling; Frances Milat
Journal:  JBMR Plus       Date:  2022-01-19

5.  Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients.

Authors:  Polyzois Makras; Panagiotis Petrikkos; Athanasios D Anastasilakis; Artemis Kolynou; Angeliki Katsarou; Olga Tsachouridou; Symeon Metallidis; Maria P Yavropoulou
Journal:  Bone Rep       Date:  2021-09-10

6.  The Effect of Modern Antiretroviral Therapy on Complication Rates After Total Hip Arthroplasty.

Authors:  Oliver C Sax; Nequesha S Mohamed; Sahir S Pervaiz; Scott J Douglas; Albert J Aboulafia; Ronald E Delanois
Journal:  JB JS Open Access       Date:  2021-05-04

7.  The Golden Compass Program: Overview of the Initial Implementation of a Comprehensive Program for Older Adults Living with HIV.

Authors:  Meredith Greene; Janet Myers; Judy Y Tan; Cinthia Blat; Allison O'Hollaren; Francisco Quintanilla; Priscilla Hsue; Mary Shiels; Mary Lawrence Hicks; Bill Olson; Janet Grochowski; Jon Oskarsson; Diane Havlir; Monica Gandhi
Journal:  J Int Assoc Provid AIDS Care       Date:  2020 Jan-Dec

Review 8.  Influence of HIV Infection and Antiretroviral Therapy on Bone Homeostasis.

Authors:  María Victoria Delpino; Jorge Quarleri
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-02       Impact factor: 5.555

9.  Vitamin D and Calcium Supplement Attenuate Bone Loss among HIVInfected Patients Receiving Tenofovir Disoproxil Fumarate/Emtricitabine/ Efavirenz: An Open-Label, Randomized Controlled Trial.

Authors:  Patawee Boontanondha; Hataikarn Nimitphong; Suchawadee Musikarat; Aschara Ragkho; Sasisopin Kiertiburanakul
Journal:  Curr HIV Res       Date:  2020       Impact factor: 1.581

10.  The burden of non-communicable diseases and mortality in people living with HIV (PLHIV) in the pre-, early- and late-HAART era.

Authors:  N A Jespersen; F Axelsen; J Dollerup; M Nørgaard; C S Larsen
Journal:  HIV Med       Date:  2021-02-28       Impact factor: 3.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.